Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.  |
AIDS TREATMENT NEWS - October 26, 2004
John S. James
Summary: A study of medical records found that combining the antibiotic erythromycin with strong inhibitors of the liver enzyme CYP3A increased the risk of sudden death from cardiac causes -- probably by abnormally raising the blood levels of erythromycin.
----------------------------------------
The November 2004 HIV AIDS Treatment Insider (published by the American Foundation for AIDS Research) has a short overview of the controversy around using Kaletra alone for HIV treatment for some patients -- mainly as an option for those who would otherwise have no antiretroviral treatment because they could not afford it.(1) A trial in Houston, Texas with 30 patients reported 48-week data at the big AIDS conference in Bangkok, Thailand in July.
The article, a fair presentation of both sides, also mentions other research plans for testing antiretroviral regimens with fewer than three drugs.
Note: The complete HIV AIDS Treatment Insider has two additional important articles: "Drug Pipelines May Flourish, But Not for HIV," by Kristen Kresge, and "Crunching the Numbers on Pharmaceuticals," by Elizabeth Paukstis. The complete issue can be read on the Web (or downloaded in PDF) at
http://web.amfar.org/treatment/HIV+/insidermenu.asp
References
(1) Monotherapy: An old strategy garners new interest, by Elizabeth Paukstis. HIV AIDS Treatment Insider; November 2004, volume 5, number 7,
http://www.amfar.org/cgi-bin/iowa/td/feature/record.html?record=133
041026
ATN041004
Copyright © 2004 - by John S. James. See "Permission to Copy" at: http://www.aidsnews.org/canhelp. How to help AIDS Treatment News: http://www.aidsnews.org/canhelp.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .